{
    "applicationNumber": "BR 11 2022 014382-6",
    "filingDate": "22/01/2021",
    "grantDate": null,
    "title": "REDU\u00c7\u00c3O DOS EFEITOS COLATERAIS DE ANTAGONISTAS NMDA",
    "nationalPhaseDate": [
        "20/07/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2021/014748",
        "pctDate": "22/01/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/964,598",
            "priorityDate": "22/01/2020"
        },
        {
            "countryCode": "US",
            "priorityNumber": "63/079,791",
            "priorityDate": "17/09/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2691"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2697"
        }
    ],
    "inventors": [
        "RAJ MEHRA",
        "TIMOTHY WHITAKER"
    ],
    "holders": [
        313019
    ],
    "ipcCodes": [
        "A61K 31/135",
        "A61P 25/24"
    ]
}